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Predicting the Risk of Tumor
Occurrence under the Effect
of Small Doses of Carcinogens
by N. Ya. Yanysheva* and Yu. G. Antomonov*
Basic methodological approaches were formulated for determining the permissible
levels of carcinogens in man's environment on the basis of current experimental oncologi-
cal data dealing with the interaction of the organism and carcinogenic compounds. The
tumor is proposed as a specific index ofthe harmfulness criterion of carcinogenic action.
Under these conditions, both the frequency and the development time of tumors must be
considered.
Results are given of an experimental study ofthe carcinogenic activity ofvarious doses of
benz[a]pyrene (0.005, 0.02, 0.1, 0.5, and 2.5 mg) on rats by using a tenfold intratracheal ad-
ministration. On the basis of mathematical models of the obtained dose-time-effect relation-
ship, the risk of cancer occurrence due to small carcinogen doses is predicted. Small doses
were not tested in the experiment.
On the basis ofthe data obtained in the experiment, a maximally permissible concentration
of benz a pyrene in the ambient air can be determined. A benz[a]pyrene dose of 0.02 mg is
recommended as the basis of the calculation. The effect of this dose is shown at time periods
longer than the limits of human life.
Quantitative criteria of the action of chemical
carcinogenic compounds serve as the basis for
establishing the degree of danger they pose and
safety levels.
Since it is still not clear at this time whether an
effect threshold exists for carcinogenic substances,
the real task is to determine the specific effect
which may appear beyond the limits ofhuman life.
This would serve as a tolerable carcinogen dose.
This can be done by developing a model for the
quantitative relationship of the effect of a car-
cinogenic agent under oncologic experimental con-
ditions, with subsequent extrapolation of the data
to man.
This includes: (1) study of various doses of car-
cinogen in the range of optimal to minimally effec-
tive and maximumly ineffective doses with obser-
vation of the animals during their life span; (2)
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mathematical modelling of the carcinogen
dose-blastomogenic effect and the relationship of
carcinogen dose to time of effect; (3) the quantita-
tive prediction ofthe theoretical risk ofappearance
ofa tumor as a result ofthe action ofsmall doses of
carcinogen during the time period beyond the limit
of the maximum duration of animal life; (4)
calculation ofmaximum permissible concentration
(MPC) ofcarcinogen in the appropriate elements of
the environment.
Since it was not possible to conduct the detailed
experimental studies in accord with the general re-
quirements of experimental oncology, let us ex-
amine some of the principal considerations.
One of the most complex and the least studied
problems is that of the extrapolation of data ob-
tained on animals to humans. For this reason, in
conducting studies on the establishment of stan-
dards for carcinogens, it is important to make test
conditions as realistic as possible, in particular
with respect to the introduction ofthe carcinogenic
agent into the organism.
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suitability of experimental models for forms of
tumors observed in the pathology ofman. The com-
plexity of this problem must be stated, since it is
known that tumor form and localization depend not
only on the species of laboratory animal and the
mechanisms oftransformation ofcarcinogenic agent
in each of the species, but also to a great extent on
the carcinogen dose and the conditions and duration
ofcarcinogen contact with organs and tissues. Thus,
for example, in ourstudies we observed thatthe dose
of benzpyrene has an effect on the histological type
of lung cancer. This is shown by the dominant
development of epidermoid cancer with the ad-
ministration oflarge doses and the tendencytowards
the development of adenocarcinoma at lower doses
(1).
Pylev and Grisyute, each, administered identical
doses of dimethylbenzanthracene (DMBA) to
Wistar strain rats. Lung cancer resulted in the
same number of instances; approximately 30% of
the animals developed lung cancer. Nevertheless in
Pylev's tests, epidermoid cancer predominated
with keratinization, and the premalignant changes
consisted of metaplasia, while in Gritsyute's tests,
the tumors appeared later and were primarily
represented by undifferentiated adenocarcinomoid
forms. This is most likely explained by the
difference in the conditions of administration:
Gritsyute used long administration periods with
large intervals, while Pylev used "shock" doses
with small intervals which evoked metaplasia (2).
Turusov (3) observed the effect of carcinogen
dose on the histologic structure of cancer in the case
ofcutaneouscarcinogenesis. Arkhipov (4) produced
tumors inthebodyofthe stomach ofmice during ex-
perimental disruption of its functional state (reduc-
tion ofsecretion) byintroducingephedrine chloride.
Introduction of a carcinogen with food results in
damage to the forestomach due to longer contact
with the mucosa of the forestomach while the
entrance of the same carcinogen into an empty
stomach also produces tumors invarious sections of
the intestines. The given data show the necessity of
taking into consideration the entire blastomogenic
reaction of an organism asthe response to the action
of a carcinogenic factor.
The use in experiments of animals with various
spontaneous tumor levels remains a debatable
question. It would seem advisable to use animals
with high cancer susceptibility in determining the
effect of small carcinogen doses, since as Shabad
(5) points out, spontaneous tumors in themselves
attest to a sensitivity to blastomogenic substances.
In conjunction with this, our studies (6) showed
that minimally effective doses induce single tumors
at the end of the natural life of an animal. This in
time coincides with the development of spon-
taneous tumors. Thus against this background, it is
not possible to differentiate the induced tumors.
The increase in the frequency of spontaneous
tumors in in-bred animals under the effect of a car-
cinogenic factor depends entirely on the genetic
properties of the animal strain selected for testing
(7).
At the same time, random-bred animals are
genetically heterogeneous. This makes them a
closer approximation to the human population and
on this basis it is more advisable to use such
animals in this type of experiment.
So far as the duration of exposure is concerned,
there undoubtedly is a need for further scientific
elaboration. Based on our experience, two types of
procedures are possible and each one has its own
advantages.
Procedure 1 consists of the administration of
standard carcinogen over the entire lifespan of
animals. This method is optimal with respect to
public health applications, since it approximates
real conditions, but it is exceedingly complex and
laborious with respect to implementation.
Procedure 2 consists of administration of a car-
cinogen to several groups of animals at different
fractionations. Results obtained in such an experi-
ment provide considerably more information and
can serve as a basis for a mathematical model of
dose-time effect. This will make it possible to use
these results to predict the effect of the chronic ac-
tion of a carcinogen on the basis of the results of a
short-term experiment.
On the basis of these data, there emerges the
possibilityofdetermining thecoefficient ofcumula-
tion, which is an important index of the charac-
teristics of the biological effect of a carcinogen.
Another important problem is the determination
of criteria of harmful activity. In spite of the large
amount of information available by experimental
oncology on correlations between the carcinogenic
factor and the organism and subsequently between
tumor and the organism, up to the present there are
no specific indices for defining the initial stages of
the neoplastic process before appearance ofa tumor.
Although the specificity of the tumor process is
ordained as early as the first stages of car-
cinogenesis, still it is difficult to determine on a
Environmental Health Perspectives 96Table 1. Appearance of tumors in random-bred rats after a tenfold intratracheal administration of various total benzpyrene
doses.
Number
of Epithelial tumors of the lungs Reticulosarcoma of Tumors localized
Benz- animals Malignant Benign the lungs elsewhere
pyrene receiving Time to Time to Time to Time to
dose, total occurrence, occurrence, occurrence, occurrence,
mg dose % months % months % months % months
25.0 40 32.5 14.4 37.5 12.8 10.0 15.5 5.0a,b 16.0
2.5 25 21.4 17.1 14.3 17.3 7.1 17.2 3.6c 22.5
0.5 32 15.7 25.1 12.5 19.1 - 3.1b 24.3
0.1 28 14.4 27.0 3.6c 26.7
0.02 16 - -
0.005 17
Control 21 9.5b d 24.0
aCancer ofthe bladder.
hSarcoma ofthe liver.
'Fibroadenoma ofthe mammary gland.
'1Lymphosarcoma ofthe mediastinum.
practical level whether initial changes are pre-
malignant or bear some other nonspecific nature,
for example inflammatory. Therefore at this stage,
we should consider the formation of tumors as a
reliable index of the specific action of carcinogens.
Under these conditions it is both necessary to take
into consideration the frequency and time to ap-
pearance as well as the fact that tumor frequency is
determined both by the number of inducible
neoplasms and by a higher level of spontaneous
tumors.
The hypotheses presented are used as the basis
in predicting risk from the effect of small doses of
benzpyrene. We studied a number of benzpyrene
doses in the 0.005 to 25 mg range with tenfold in-
tratracheal administration to random-bred white
rats (Table 1).
Under these conditions tumors were obtained in
the lungs and other organs of the animals. The
long-term neoplasms were singular and diverse
with respect to histologic type. This made it possi-
ble to study them as spontaneous and independent
ofthe action ofbenzpyrene. Epithelial tumors were
observed in the lungs. As is known, this type of
tumor is not encountered as a spontaneous
manifestation in rats (8-11) and also the connec-
tive tumors of the reticulosarcoma type. The latter
type significantly exceeded the spontaneous Level
which is 0.8-1.3% according to the data of Ird and
Konoplev (9) and A. I. Vysamyae (11).
On the basis of the data in Table 1, the number
tumor-bearing animals diminishes as the
benzpyrene dose is reduced. The time for ap-
pearance of a neoplasm increases, and as a result,
the number of spontaneous lung tumors also in-
creases. A shortening of the latent period for lung
tumor development occurs only under the effect of
large benzpyrene doses. Small doses of the com-
pound resulted in including only epithelial
neoplasms. In this experiment, the total dose of0.1
mg is minimally effective and 0.02 and 0.005 mg are
ineffective.
In analyzing the data, we must say a few words
about the given conditionality or dynamicity which
is dependent on the experimental conditions associ-
ated with such values as the minimally effective
and ineffective dose. Thus for example, a
benzpyrene dose of 0.1 mg administered once and
five times does not produce tumors (Table 2), but a
tumorigenic effect ofthis dose was shown after ten-
fold fractional introduction.* One question that re-
mains unclear is concerned with the potential
danger of the maximally noneffective dose of 0.02
mg obtained in our experiment. How potentially
dangerous is this dose if it is administered daily
throughout the life ofan animal, rather than over a
10-month period as we did it?
Finally, let us look at sensitivity. The fact is that
our studies were conducted on relatively small
*Editor's note: X-fold (fractional) introduction appears to
indicate that the a given total dose was divided intox portions,
administered in x doses.
February 1976 97Table 2. Appearance of lung tumors as a function of the number of doses of benzpyrene.
Incidence of lung tumors, %
Total 1 dose 5 doses 10 doses 36 doses
dose, mg Experimental Theoreticala Experimental Theoreticala Experimental Theoreticala (theoreticala)
25.0 30.0 14.7 55.5 55.1 80.0 79.8 99.6
10.0 27.2 10.2 41.5 65.6 97.9
2.5 13.0 5.4 24.3 42.8 42.6 86.5
0.5 5.9 3.3 - 5.5 28.2 28.4 70.0
0.1 0.0 0.9 0.0 4.9 14.4 9.4 30.0
0.02 - 0.1 0.0 0.9 0.0 2.1 6.9
aTheoretical values calculated according to the formula:y = 100(1-e -ar), wherey is the risk oftumors in animals (in % ); a is an
index of risk increase, determined according to the graph dependence a = f (D), r is the number of portions into which total dose is
divided.
groups of animals. Under these conditions, there is
great variation in the sensitivity of the individuals
constituting the group to carcinogenic substances.
For this reason, instead of a sharply expressed
threshold, the dose-response curve can have a long
tail. Under certain assumptions, this can be deter-
mined through the approximation of the experi-
mental data byusing mathematical models. We did
this by using the logarithmic function equation, eq.
(1), plotted in Figure 1.:
Y = 10 lIn [(Xn/X)]+ 1 (1)
where Yisthe percentage ofanimalswithtumors, 4X
is the carcinogen dose (in mg), and X is the max-
imally noneffective dose (in mg) and also by using
the exponential equation [eq. (2)] plotted in Figure
2:
Y = 100 (1 - e-ax) (2)
where Y is the percentage of animals with tumors,
x is the carcinogen dose (in mg), and a is the coeffi-
cient of proportionality and dimensionality; a =
100
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FIGURE 1. Frequency oflung tumors as a function ofthe
benzpyrene dose administered to the respiratory tract of
random-bred rats (functional logarithmic equation): (o)
experimental; (.) points computed with the function
Y=10ln[(Xn/X)] + 1.
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FIGURE 2. Frequency oflung tumors as a function ofthe
benzpyrene dose administered to the respiratory tract of
random-bred rats [functional exponential relationship,
Y=100(1-e -ax)].
1.555 when the exponential curve passes through
the 0.1 mg point and a = 0.064 when the exponen-
tial curve passes through the 25 mg point.
As can be seen, the quasithreshold includes a
broad range of benzpyrene doses (Fig. 1). Those
benzpyrene doses which turned out to be ineffective
in the experiment may under certain conditions in-
duce neoplasms. We utilized a supplementary
dose-time relationship in order to establish a bet-
ter basis for the selection of the allowable
benzpyrene dose. To calculate the theoretical oc-
currence time of the first tumor T as function of
small benzpyrene doses d [eq. (3)] was used:
T=(a/d)+B (3)
where a = 1.021 and B = 16.79.
Table 3 shows the computed occurrence time for
the initial (first) tumor. As can be seen from Table
3, the latency period for the initial tumor is 27
months in the case of a 0.1 mg dose tested in the ex-
periment. The occurrence time for the initial tumor
resulting from a dose two times less than the above
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98Table 3. Calculated time for appearance of the first lung
tumor after administration of various total benzpyrene
doses in ten portions intratracheally.
Benzpyrene dose, Time of tumor
mg occurrence, months
0.1 27.0
0.05 38
0.02 67.9
0.01 118.9
0.005 221.0
0.002 527.3
is predicted at 38 months, i.e., towards the end of
the animal's lifespan. Smaller doses induce initial
neoplasms past the lifespan limits of the animal.
We recommend a 0.02 mg dose as the permissi-
ble dose and consider that it is possible to use this
dose for calculation in the dose-concentration for-
mula.
Thus despite the given theoretical risk of tumor
occurrence resulting from the effect of small car-
cinogen doses, there exists the possibility of deter-
mining such doses whose effect may manifest itself
only past the lifespan limits of the animal.
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